In which John shares an extraordinary update: Johnson & Johnson has confirmed they will not enforce secondary patents on bedaquiline in ANY low- or middle-income country. The agreement applies to 134 nations, and it is essentially everything that we've been asking for. Astonishing. Wondrous.
